MADISON, Wis. (AP) _ Exact Sciences Corp. (EXAS) on Tuesday reported a loss of $219.9 million in its third quarter.
The Madison, Wisconsin-based company said it had a loss of $1.46 per share. Losses, adjusted for asset impairment costs, were 36 cents per share.
The results exceeded Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for a loss of 51 cents per share.
The molecular diagnostics company posted revenue of $408.4 million in the period, also beating Street forecasts. Seven analysts surveyed by Zacks expected $351 million.
Exact Sciences shares have risen 15% since the beginning of the year. The stock has increased 20% in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on EXAS at https://www.zacks.com/ap/EXAS
Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News